Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Apexbio Technology LLC Pneumocandin B0 135575-42-7 1mg
SDP

Catalog No. 5000089539
Encompass_Preferred

Pneumocandin B0 (CAS 135575-42-7) is a small-molecule inhibitor targeting -(1 3)-D-glucan synthase It is designed to inhibit this enzyme thereby disrupting fungal cell wall biosynthesis Pneumocandin B0 exerts its biological activity primarily through inhibition of -(1 3)-D-glucan synthase In experimental studies Pneumocandin B0 demonstrates effective inhibition across multiple fungal strains with IC50 values typically observed in the low nanomolar range Based on these pharmacological properties Pneumocandin B0 holds research potential as a reference compound for studying fungal cell wall biosynthesis pathways and as a lead compound in antifungal drug discovery programs

Catalog No. 50-000-89539 Supplier Apexbio Technology LLC Supplier No. B47241
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Pneumocandin B0 (CAS 135575-42-7) is a small-molecule inhibitor targeting -(1 3)-D-glucan synthase It is designed to inhibit this enzyme thereby disrupting fungal cell wall biosynthesis Pneumocandin B0 exerts its biological activity primarily through inhibition of -(1 3)-D-glucan synthase In experimental studies Pneumocandin B0 demonstrates effective inhibition across multiple fungal strains with IC50 values typically observed in the low nanomolar range Based on these pharmacological properties Pneumocandin B0 holds research potential as a reference compound for studying fungal cell wall biosynthesis pathways and as a lead compound in antifungal drug discovery programs

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.